Crossmark

Daily combined measurement of platelet count and presepsin concentration can predict in-hospital death of patients with severe coronavirus disease 2019 (COVID-19)

Crossref DOI link: https://doi.org/10.1007/s12185-023-03555-5

Published Online: 2023-03-15

Published Print: 2023-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ishikura, Hiroyasu https://orcid.org/0000-0002-4862-5646
Maruyama, Junichi

Nakashio, Maiko

Hoshino, Kota

Morimoto, Shinichi

Izutani, Yoshito

Noake, Junta

Yamagaito, Takahiro

Yoshida, Maho

Kitamura, Taisuke

Nakamura, Yoshihiko
License Information

Text and Data Mining valid from 2023-03-15

Version of Record valid from 2023-03-15
More Information

Article History

Received: 16 December 2022

Revised: 31 January 2023

Accepted: 1 February 2023

First Online: 15 March 2023

Declarations

:

: Takahiro Yamagaito and Maho Yoshida are employees of Sysmex Corporation. The other authors declare that they have no conflict of interest.

: We obtained signed informed consent from the patients or their proxies in accordance with the Declaration of Helsinki for publication of this study. A copy of the informed consent document can be provided upon request.

Document is current

Any future updates will be listed below